Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2016

Open Access 01-12-2016 | Case report

Loxoprofen-induced interstitial pneumonia: a case report

Authors: Motoyasu Kato, Shinichi Sasaki, Yasuhito Sekimoto, Naoko Arano, Hitomi Jo, Kentaro Suina, Sachiko Kuriyama, Keiko Muraki, Osamu Nagashima, Yasuko Yoshioka, Shigeru Tominaga, Kazuhisa Takahashi

Published in: Journal of Medical Case Reports | Issue 1/2016

Login to get access

Abstract

Background

Loxoprofen is a nonsteroidal anti-inflammatory drug used in the treatment of many diseases. However, there are no case reports about loxoprofen-induced pneumonia. We have encountered a rare case of loxoprofen-induced pneumonia.

Case presentation

We report the case of a 71-year-old Japanese woman who was initially treated with loxoprofen for fever. She was admitted to our hospital because of worsening of her symptoms, including fever and dyspnea. Her symptoms improved after treatment with ceftriaxone. Seven days after admission, she again developed high fever. She was again treated with loxoprofen and levofloxacin. However, acute respiratory failure developed after initiation of loxoprofen treatment. Chest computed tomography showed peribronchovascular consolidation. She was diagnosed with loxoprofen-induced pneumonia for which she was administered steroids. After treatment, her dyspnea and radiological findings improved.

Conclusions

The findings in this case report reveal an association between treatment with a nonsteroidal anti-inflammatory drug and pneumonia. This rare case was diagnosed after accidental retreatment with loxoprofen. This is the first report of loxoprofen-induced pneumonia.
Literature
1.
go back to reference Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239–45.CrossRefPubMed Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239–45.CrossRefPubMed
2.
go back to reference Ii T, Doutsu Y, Ashitani J, Taniguchi H, Mizuta M, Toshimori H, et al. A case of loxoprofen-induced pulmonary eosinophilia. Nihon Kyobu Shikkan Gakkai Zasshi. 1992;30:926–9.PubMed Ii T, Doutsu Y, Ashitani J, Taniguchi H, Mizuta M, Toshimori H, et al. A case of loxoprofen-induced pulmonary eosinophilia. Nihon Kyobu Shikkan Gakkai Zasshi. 1992;30:926–9.PubMed
3.
go back to reference Tohyama M, Tamaki Y, Toyama M, Ishimine T, Miyazato A, Nakamoto A, et al. A case of loxoprofen-induced pneumonitis pathologically resembling hypersensitivity pneumonitis. Nihon Kokyuki Gakkai Zasshi. 2002;40:123–8.PubMed Tohyama M, Tamaki Y, Toyama M, Ishimine T, Miyazato A, Nakamoto A, et al. A case of loxoprofen-induced pneumonitis pathologically resembling hypersensitivity pneumonitis. Nihon Kokyuki Gakkai Zasshi. 2002;40:123–8.PubMed
4.
go back to reference Cohen MH, Williams GA, Sridhara R, Chen G, Pazdur R. FDA drug approval summary: gefitinib (ZD1839) (Iressa) tablets. Oncologist. 2003;8:303–6.CrossRefPubMed Cohen MH, Williams GA, Sridhara R, Chen G, Pazdur R. FDA drug approval summary: gefitinib (ZD1839) (Iressa) tablets. Oncologist. 2003;8:303–6.CrossRefPubMed
5.
go back to reference Seibold MA, Wise AL, Speer MC, Steele MP, Brown KK, Loyd JE, et al. A common MUC5B promoter polymorphism and pulmonary fibrosis. N Engl J Med. 2011;364:1503–12.CrossRefPubMedPubMedCentral Seibold MA, Wise AL, Speer MC, Steele MP, Brown KK, Loyd JE, et al. A common MUC5B promoter polymorphism and pulmonary fibrosis. N Engl J Med. 2011;364:1503–12.CrossRefPubMedPubMedCentral
6.
go back to reference Horimasu Y, Ohshimo S, Bonella F, Tanaka S, Ishikawa N, Hattori N, et al. MUC5B promoter polymorphism in Japanese patients with idiopathic pulmonary fibrosis. Respirology. 2015;20:439–44.CrossRefPubMed Horimasu Y, Ohshimo S, Bonella F, Tanaka S, Ishikawa N, Hattori N, et al. MUC5B promoter polymorphism in Japanese patients with idiopathic pulmonary fibrosis. Respirology. 2015;20:439–44.CrossRefPubMed
7.
go back to reference Camus P, Fanton A, Bonniaud P, Camus C, Foucher P. Interstitial lung disease induced by drugs and radiation. Respiration. 2004;71:301–26.CrossRefPubMed Camus P, Fanton A, Bonniaud P, Camus C, Foucher P. Interstitial lung disease induced by drugs and radiation. Respiration. 2004;71:301–26.CrossRefPubMed
8.
go back to reference Pichler WJ, Tilch J. The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy. 2004;59:809–20.CrossRefPubMed Pichler WJ, Tilch J. The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy. 2004;59:809–20.CrossRefPubMed
9.
go back to reference Cleverley JR, Screaton NJ, Hiorns MP. Drug-induced lung disease: high-resolution CT and histological findings. Clin Radiol. 2002;57:292–9.CrossRefPubMed Cleverley JR, Screaton NJ, Hiorns MP. Drug-induced lung disease: high-resolution CT and histological findings. Clin Radiol. 2002;57:292–9.CrossRefPubMed
Metadata
Title
Loxoprofen-induced interstitial pneumonia: a case report
Authors
Motoyasu Kato
Shinichi Sasaki
Yasuhito Sekimoto
Naoko Arano
Hitomi Jo
Kentaro Suina
Sachiko Kuriyama
Keiko Muraki
Osamu Nagashima
Yasuko Yoshioka
Shigeru Tominaga
Kazuhisa Takahashi
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2016
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-016-0919-2

Other articles of this Issue 1/2016

Journal of Medical Case Reports 1/2016 Go to the issue